{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:20:44Z","timestamp":1794716444954,"version":"4.9.1"},"reference-count":38,"publisher":"American Society for Microbiology","issue":"10","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2005,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            <jats:italic>Salmonella enterica<\/jats:italic>\n            serovar Typhi is an important pathogen exclusively for humans and causes typhoid or enteric fever. It has been shown that type IVB pili, encoded by the\n            <jats:italic>S. enterica<\/jats:italic>\n            serovar Typhi\n            <jats:italic>pil<\/jats:italic>\n            operon located in\n            <jats:italic>Salmonella<\/jats:italic>\n            pathogenicity island 7, are important in the pathogenic process. In this study, by using both an adhesion-invasion assay and fluorescence quantitative PCR analysis, we demonstrated that the entry of type IVB piliated\n            <jats:italic>S. enterica<\/jats:italic>\n            serovar Typhi A21-6 (\n            <jats:italic>pil<\/jats:italic>\n            <jats:sup>+<\/jats:sup>\n            Km\n            <jats:sup>r<\/jats:sup>\n            ) into human THP-1 monocytic cells was greater than that of a nonpiliated\n            <jats:italic>S. enterica<\/jats:italic>\n            serovar Typhi\n            <jats:italic>pilS<\/jats:italic>\n            ::Km\n            <jats:sup>r<\/jats:sup>\n            (\n            <jats:italic>pil<\/jats:italic>\n            mutant) strain. We have applied a systematic evolution of ligands by exponential enrichment approach to select oligonucleotides (aptamers) as ligands that specifically bind to type IVB pili. Using this approach, we identified a high-affinity single-stranded RNA aptamer (S-PS\n            <jats:sub>8.4<\/jats:sub>\n            ) as a type IVB pilus-specific ligand and further found that the selected aptamer (S-PS\n            <jats:sub>8.4<\/jats:sub>\n            ) could significantly inhibit the entry of the piliated strain (but not that of the nonpiliated strain) into human THP-1 cells. The binding affinities between aptamers and pre-PilS (structural protein of type IVB pili) were determined by nitrocellulose filter-binding assays, and the\n            <jats:italic>\n              K\n              <jats:sub>d<\/jats:sub>\n            <\/jats:italic>\n            value was determined to be 8.56 nM for the S-PS\n            <jats:sub>8.4<\/jats:sub>\n            aptamer alone. As an example of an aptamer against type IVB pili of\n            <jats:italic>S. enterica<\/jats:italic>\n            serovar Typhi, the aptamer S-PS\n            <jats:sub>8.4<\/jats:sub>\n            can serve as a tool for analysis of bacterial type IVB pilus-host cell interactions and may yield information for the development of putative new drugs against\n            <jats:italic>S. enterica<\/jats:italic>\n            serovar Typhi bacterial infections, useful both in prevention of infection and in therapeutic treatment.\n          <\/jats:p>","DOI":"10.1128\/aac.49.10.4052-4060.2005","type":"journal-article","created":{"date-parts":[[2005,9,27]],"date-time":"2005-09-27T16:28:08Z","timestamp":1127838488000},"page":"4052-4060","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":104,"title":["Aptamers That Preferentially Bind Type IVB Pili and Inhibit Human Monocytic-Cell Invasion by\n            <i>Salmonella enterica<\/i>\n            Serovar Typhi"],"prefix":"10.1128","volume":"49","author":[{"given":"Qin","family":"Pan","sequence":"first","affiliation":[{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Lian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Immunology"},{"name":"Hubei Province Key Laboratory of Allergy and Immunology, Wuhan University School of Medicine"},{"name":"State Key Laboratory of Virology, Wuhan University, Wuhan 430072, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan-Wen","family":"He","sequence":"additional","affiliation":[{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fubin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Immunology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Sheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital, Wuhan University, Wuhan 430071"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ming","family":"Hu","sequence":"additional","affiliation":[{"name":"Hubei Province Key Laboratory of Allergy and Immunology, Wuhan University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xia","sequence":"additional","affiliation":[{"name":"Zhongnan Hospital, Wuhan University, Wuhan 430071"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Wu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Virology, Wuhan University, Wuhan 430072, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.280.5372.2114"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.8.3688-3696.2002"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1332660100"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"15416","DOI":"10.1073\/pnas.2136683100","volume":"100","year":"2003","unstructured":"Daniels, D. A., H. Chen, B. J. Hicke, K. M. Swiderek, and L. Gold. 2003. A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment. Proc. Natl. Acad. Sci. USA100:15416-15421.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.2000.01400.x"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"48644","DOI":"10.1074\/jbc.M104651200","volume":"276","year":"2001","unstructured":"Hicke, B. J., C. Marion, Y. F. Chang, T. Gould, C. K. Lynoct, D. Parma, P. G. Schmidt, and S. Warren. 2001. Tenascin-C aptamers are generated using tumor cells and purified protein. J. Biol. Chem.276:48644-48654.","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"11363","DOI":"10.1021\/bi00036a009","volume":"34","year":"1995","unstructured":"Jellinek, D., L. S. Green, C. Bell, C. K. Lynott, N. Gill, C. Vargeese, G. Kirschenheuter, D. P. McGee, P. Abesinghe, W. A. Pieken, R. Shapiro, D. B. Rifkin, D. Moscatelli, and N. Janjc. 1995. Potent 2\u2032-amino-2\u2032-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor. Biochemistry34:11363-11372.","journal-title":"Biochemistry"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.13.6545-6557.2002"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0014-5793(98)01572-5","volume":"441","year":"1998","unstructured":"Kimoto, M., K. Sakamoto, M. Shirouzu, I. Hirao, and S. Yokoyama. 1998. RNA aptamers that specifically bind to the Ras-binding domain of Raf-1. FEBS Lett.441:322-326.","journal-title":"FEBS Lett."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkf552"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.4.1018"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1074\/jbc.M107130200","volume":"277","year":"2002","unstructured":"Meli, M., J. Vergne, J. L. Decout, and M. C. Maurel. 2002. Adenine-aptamer complexes: a bipartite RNA site that binds the adenine nucleic base. J. Biol. Chem.277:2104-2111.","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1073\/pnas.95.6.2902","volume":"95","year":"1998","unstructured":"Morris, K. N., K. B. Jensen, C. M. Julin, M. Weil, and L. Gold. 1998. High affinity ligands from in vitro selection: complex targets. Proc. Natl. Acad. Sci. USA95:2902-2907.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2003.08.001"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.3.1141-1146.2003"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0014-4894(03)00137-1","volume":"104","year":"2003","unstructured":"Naguleswaran, A., N. Muller, and A. Hemphill. 2003. Neospora caninum and Toxoplasma gondii: a novel adhesion\/invasion assay reveals distinct differences in tachyzoite-host cell interactions. Exp. Parasitol.104:149-158.","journal-title":"Exp. Parasitol."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1073\/pnas.93.12.5883","volume":"93","year":"1996","unstructured":"O'Connell, D., A. Koenig, S. Jennings, B. Hicke, H. L. Han, T. Fitwater, Y. F. Chang, N. Varki, D. Parma, and A. Varki. 1996. Calcium-dependent oligonucleotide antagonists specific for l-selectin. Proc. Natl. Acad. Sci. USA93:5883-5887.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.185.17.5055-5065.2003"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"11416","DOI":"10.1074\/jbc.M109752200","volume":"277","year":"2002","unstructured":"Proske, D., M. Hofliger, R. M. Soll, A. G. Beck-Sickinger, and M. Famulok. 2002. A Y2 receptor mimetic aptamer directed against neuropeptide Y. J. Biol. Chem.277:11416-11422.","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.184.17.4846-4856.2002"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"28555","DOI":"10.1074\/jbc.M002981200","volume":"275","year":"2000","unstructured":"Rhodes, A., A. Deakin, J. Spaull, B. Coomber, A. Aitken, P. Life, and S. Rees. 2000. The generation and characterization of antagonist RNA aptamers to human oncostatin M. J. Biol. Chem.275:28555-28561.","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0014-5793(01)02895-2","volume":"506","year":"2001","unstructured":"Rhodes, A., N. Smithers, T. Chapman, S. Parsons, and S. Rees. 2001. The generation and characterization of antagonist RNA aptamers to MCP-1. FEBS Lett.506:85-90.","journal-title":"FEBS Lett."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.9.5619-5625.2001"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(92)90870-P"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.185.15.4410-4417.2003"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.1.22-28.2004"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6976.2002.tb00606.x"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2200121"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"14051","DOI":"10.1073\/pnas.95.24.14051","volume":"95","year":"1998","unstructured":"Ulrich, H., J. E. Ippolito, O. R. Pagan, V. A. Eterovic, R. M. Hann, H. Shi, J. T. Lis, M. E. Eldefrawi, and G. P. Hess. 1998. In vitro selection of RNA molecules that displace cocaine from the membrane-bound nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. USA95:14051-14056.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"20756","DOI":"10.1074\/jbc.M111859200","volume":"277","year":"2002","unstructured":"Ulrich, H., M. H. Magdesian, M. J. Alves, and W. Colli. 2002. In vitro selection of RNA aptamers that bind to cell adhesion receptors of Trypanosoma cruzi and inhibit cell invasion. J. Biol. Chem.277:20756-20762.","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1093\/nar\/29.12.2479","volume":"29","year":"2001","unstructured":"Venables, J. P., M. Ruggiu, and H. J. Cooke. 2001. The RNA-binding specificity of the mouse Dazl protein. Nucleic Acids Res.29:2479-2483.","journal-title":"Nucleic Acids Res."},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1073\/pnas.0831159100","volume":"100","year":"2003","unstructured":"White, R. R., S. Shan, C. P. Rusconi, G. Shetty, M. W. Dewhirst, C. D. Kontos, and B. A. Sullenger. 2003. Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2. Proc. Natl. Acad. Sci. USA100:5028-5033.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1074\/jbc.M008982200","volume":"276","year":"2001","unstructured":"Xu, A., and K. Y. Chen. 2001. Hypusine is required for a sequence-specific interaction of eukaryotic initiation factor 5A with postsystematic evolution of ligands by exponential enrichment RNA. J. Biol. Chem.276:2555-2561.","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M404727200"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0022-4804(02)00040-9","volume":"109","year":"2003","unstructured":"Yukiue, H., H. Sasaki, Y. Kobayashi, Y. Nakashima, S. Moriyama, M. Yano, M. Kaji, M. Kiriyama, I. Fukai, Y. Yamakawa, and Y. Fujii. 2003. Clinical significance of tissue inhibitor of metalloproteinase and matrix metalloproteinase mRNA expression in thymoma. J. Surg. Res.109:86-91.","journal-title":"J. Surg. Res."},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1119(97)00466-6"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.6.3067-3073.2000"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.12.5567-5575.2001"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.49.10.4052-4060.2005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.49.10.4052-4060.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T18:41:40Z","timestamp":1645468900000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.49.10.4052-4060.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["10.1128\/AAC.49.10.4052-4060.2005"],"URL":"https:\/\/doi.org\/10.1128\/aac.49.10.4052-4060.2005","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"2005-05-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-07-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-10-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}